Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@ASX_IHL](/creator/twitter/ASX_IHL)
"IHL-42X's positive topline results from its Phase X #clinicaltrial confirm statistically significant & clinically meaningful improvements across key endpoints reinforcing its potential as a best-in-class therapy for patients. Learn more here: $IXHL"  
[X Link](https://x.com/ASX_IHL/status/1975899200513769547) [@ASX_IHL](/creator/x/ASX_IHL) 2025-10-08T12:20Z 4850 followers, 26.6K engagements


"$IXHL's CMO Lou Barbato M.D. spoke with @GoHealio about our phase X #clinicaltrial of PSX-001 a psilocybin-assisted treatment for generalized anxiety disorder. Read the full Q&A discussion here:"  
[X Link](https://x.com/ASX_IHL/status/1978894371505230098) [@ASX_IHL](/creator/x/ASX_IHL) 2025-10-16T18:42Z 4850 followers, 15.3K engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@ASX_IHL "IHL-42X's positive topline results from its Phase X #clinicaltrial confirm statistically significant & clinically meaningful improvements across key endpoints reinforcing its potential as a best-in-class therapy for patients. Learn more here: $IXHL"
X Link @ASX_IHL 2025-10-08T12:20Z 4850 followers, 26.6K engagements

"$IXHL's CMO Lou Barbato M.D. spoke with @GoHealio about our phase X #clinicaltrial of PSX-001 a psilocybin-assisted treatment for generalized anxiety disorder. Read the full Q&A discussion here:"
X Link @ASX_IHL 2025-10-16T18:42Z 4850 followers, 15.3K engagements

creator/twitter::1075579982523424769/posts
/creator/twitter::1075579982523424769/posts